针对IL-17A通路用于早期肌病的治疗
Neal L Millar1, Iain B McInnes2, Frank Kolbinger3
1School of Infection and Immunity, University of Glasgow, Glasgow, UK neal.millar@glasgow.ac.uk.
RMD open
|February 23, 2025
概括
干白素17A (IL-17A) 通过促进炎症和退化来驱动肌病. 阻断IL-17A通路显示出作为早期肌病的治疗策略的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 整形外科 整形外科 整形外科
- 分子生物学分子生物学
背景情况:
- 肌病带来了重大的临床和社会经济挑战,治疗选择有限.
- 干白素17A (IL-17A) 参与肌病变的发生.
- 了解IL-17A通路的作用对于开发新疗法至关重要.
研究的目的:
- 阐明IL-17A通路刺激和阻断在肌病的生物机制.
- 为了研究IL-17家族成员在人类旋转手腕肌病的差异表达.
- 为了评估IL-17A阻断的治疗潜力.
主要方法:
- 在人类旋转手套肌活检中对IL-17家族成员表达的RT-qPCR分析.
- IL-17A刺激人类肌衍生细胞以识别通路签名基因.
- 在大鼠模型中进行了ex vivo和in vivo研究,以评估IL-17A通路阻塞效应.
主要成果:
- 在早期人类肌病症中观察到IL-17A的差异表达.
- 激发IL-17A可以提高关键的炎症和矩阵降解基因的调节.
- 在老鼠模型中IL-17A阻塞减少了炎症,结构损伤和功能改善.
结论:
- IL-17A是肌炎症和肌病变的关键调解者.
- IL-17A阻断显示出治疗早期肌病变的前景.
- 针对IL-17A通路提供了一个潜在的新治疗策略.
相关概念视频
T Cell Types and Functions
830
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
830
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K


